Clinical Trial Update: Vorinostat, Paclitaxel, and Radiation Therapy in Treating Patients Unable to Tolerate Cisplatin With Stage III Non-Small Lung Cancer That Cannot Be Removed By Surgery [Phase 1, Phase 2]

View source ↗

Summary

This Phase 1/2 trial evaluated a vorinostat/paclitaxel/radiation therapy regimen for patients with stage III non-small cell lung cancer who cannot tolerate cisp…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• PACLITAXEL (PACLITAXEL)
• Vorinostat (vorinostat)

Snippet

Sponsor: University of Washington | Conditions: Stage IIIA Non-small Cell Lung Cancer, Stage IIIB Non-small Cell Lung Cancer | Phase 1, Phase 2 | Status: TERMINATED | Results posted: 2017-06-14